1. 40PInterest and potential of genetically engineered cord blood derived T cells for cancer immunotherapy. (17th December 2018) Authors: Marton, C; Mercier-Letondal, P; Deschamps, M; Ferrand, C; Adotevi, O; Borg, C; Galaine, J; Godet, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗